Ildong Holdings Co Ltd Cash Flow Conversion Efficiency
Ildong Holdings Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Ildong Holdings Co Ltd (000230) has a cash flow conversion efficiency ratio of 0.026x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩9.20 Billion ≈ $6.23 Million USD) by net assets (₩356.51 Billion ≈ $241.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Ildong Holdings Co Ltd (1999–2025)
Cash flow conversion efficiency of Ildong Holdings Co Ltd from 1999 to 2025. This chart illustrates how Ildong Holdings Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 000230 stock price and chart for real-time trading data and today's change.
Ildong Holdings Co Ltd Cash Flow Conversion Ratio Explained
Ildong Holdings Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Ildong Holdings Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ildong Holdings Co Ltd ranked by their cash flow conversion efficiency. Also see how much is Ildong Holdings Co Ltd worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Green Cross Medical Science Corporation
KQ:142280
|
-0.013x |
|
K Seng Seng Corporation Bhd
KLSE:5192
|
-0.071x |
|
Metal Sky Star Acquisition Corporation Ordinary shares
NASDAQ:MSSA
|
-0.003x |
|
MACH7 Technologies Ltd
AU:M7T
|
0.073x |
|
Intellicheck Mobilisa Inc
NASDAQ:IDN
|
0.080x |
|
Eversendai Corporation Bhd
KLSE:5205
|
0.039x |
|
PBG S.A
SA:PTBL3
|
0.090x |
|
CVC Technologies
TWO:4744
|
0.063x |
Annual Cash Flow Conversion Efficiency for Ildong Holdings Co Ltd (1999–2025)
The table below shows the annual cash flow conversion efficiency of Ildong Holdings Co Ltd from 1999 to 2025. Review 000230 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩345.58 Billion ≈ $234.19 Million |
₩26.86 Billion ≈ $18.21 Million |
0.078x | +14.04% |
| 2024-12-31 | ₩254.00 Billion ≈ $172.13 Million |
₩17.31 Billion ≈ $11.73 Million |
0.068x | +120.05% |
| 2023-12-31 | ₩169.90 Billion ≈ $115.14 Million |
₩-57.77 Billion ≈ $-39.15 Million |
-0.340x | +22.91% |
| 2022-12-31 | ₩169.10 Billion ≈ $114.60 Million |
₩-74.59 Billion ≈ $-50.55 Million |
-0.441x | -164.76% |
| 2021-12-31 | ₩183.34 Billion ≈ $124.25 Million |
₩-30.54 Billion ≈ $-20.70 Million |
-0.167x | -717.76% |
| 2020-12-31 | ₩305.61 Billion ≈ $207.11 Million |
₩8.24 Billion ≈ $5.59 Million |
0.027x | -39.62% |
| 2019-12-31 | ₩321.09 Billion ≈ $217.60 Million |
₩14.34 Billion ≈ $9.72 Million |
0.045x | +18.19% |
| 2018-12-31 | ₩164.95 Billion ≈ $111.78 Million |
₩6.23 Billion ≈ $4.22 Million |
0.038x | +401.14% |
| 2017-12-31 | ₩174.64 Billion ≈ $118.35 Million |
₩-2.19 Billion ≈ $-1.49 Million |
-0.013x | -102.87% |
| 2016-12-31 | ₩106.84 Billion ≈ $72.40 Million |
₩46.64 Billion ≈ $31.61 Million |
0.437x | +172.31% |
| 2015-12-31 | ₩349.98 Billion ≈ $237.18 Million |
₩56.11 Billion ≈ $38.03 Million |
0.160x | +35.63% |
| 2014-12-31 | ₩332.95 Billion ≈ $225.64 Million |
₩39.36 Billion ≈ $26.67 Million |
0.118x | +146.72% |
| 2013-12-31 | ₩326.60 Billion ≈ $221.34 Million |
₩15.65 Billion ≈ $10.60 Million |
0.048x | -15.88% |
| 2012-12-31 | ₩324.42 Billion ≈ $219.85 Million |
₩18.48 Billion ≈ $12.52 Million |
0.057x | -65.41% |
| 2011-12-31 | ₩310.17 Billion ≈ $210.20 Million |
₩51.08 Billion ≈ $34.61 Million |
0.165x | +86.76% |
| 2010-12-31 | ₩295.00 Billion ≈ $199.92 Million |
₩26.01 Billion ≈ $17.63 Million |
0.088x | -50.51% |
| 2009-12-31 | ₩280.27 Billion ≈ $189.94 Million |
₩49.93 Billion ≈ $33.84 Million |
0.178x | +114.85% |
| 2007-12-31 | ₩195.76 Billion ≈ $132.66 Million |
₩16.23 Billion ≈ $11.00 Million |
0.083x | -60.80% |
| 2006-12-31 | ₩172.99 Billion ≈ $117.23 Million |
₩36.60 Billion ≈ $24.80 Million |
0.212x | +60.45% |
| 2005-12-31 | ₩146.78 Billion ≈ $99.47 Million |
₩19.35 Billion ≈ $13.12 Million |
0.132x | -32.30% |
| 2004-12-31 | ₩124.97 Billion ≈ $84.69 Million |
₩24.34 Billion ≈ $16.49 Million |
0.195x | +387.25% |
| 2003-12-31 | ₩105.71 Billion ≈ $71.64 Million |
₩4.23 Billion ≈ $2.86 Million |
0.040x | -73.63% |
| 2002-12-31 | ₩94.84 Billion ≈ $64.27 Million |
₩14.37 Billion ≈ $9.74 Million |
0.152x | -49.07% |
| 2001-12-31 | ₩79.37 Billion ≈ $53.79 Million |
₩23.62 Billion ≈ $16.01 Million |
0.298x | +10.87% |
| 2000-12-31 | ₩66.98 Billion ≈ $45.39 Million |
₩17.98 Billion ≈ $12.18 Million |
0.268x | +40.58% |
| 1999-12-31 | ₩55.81 Billion ≈ $37.82 Million |
₩10.66 Billion ≈ $7.22 Million |
0.191x | -- |
About Ildong Holdings Co Ltd
Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the… Read more